Synthesis, enhanced fusogenicity, and solid state NMR measurements of cross-linked HIV-1 fusion peptides

被引:35
作者
Yang, R [1 ]
Yang, J [1 ]
Weliky, DP [1 ]
机构
[1] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA
关键词
D O I
10.1021/bi027052g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the HIV-1 gp41 and other viral fusion proteins, the minimal oligomerization state is believed to be trimeric with three N-terminal fusion peptides inserting into the membrane in close proximity. Previous studies have demonstrated that the fusion peptide by itself serves as a useful model fusion system, at least to the hemifusion stage in which the viral and target cell lipids are mixed. In the present study, HIV-1 fusion peptides were chemically synthesized and cross-linked at their C-termini to form dimers or trimers. C-terminal trimerization is their likely topology in the fusogenic form of the intact gp41 protein. The fusogenicity of the peptides was then measured in an intervesicle lipid mixing assay, and the assay results were compared to those of the monomer. For monomer, dimer, and trimer at peptide strand/lipid mol ratios between 0.0050 and 0.010, the final extent of lipid mixing for the dimer and trimer was 2-3 times greater than for the monomer. These data suggest that the higher local concentration of peptide strands in the cross-linked peptides enhances fusogenicity and that oligomerization of the fusion peptide in gp41 may enhance the rate of viral/target cell membrane fusion. For gp41, this effect is in addition to the role of the trimeric coiled-coil structure in bringing about apposition of viral and target cell membranes. NMR measurements on the membrane-associated dimeric fusion peptide were consistent with an extended structure at Phe-8, which is the same as has been observed for the membrane-bound monomer in the same lipid composition.
引用
收藏
页码:3527 / 3535
页数:9
相关论文
共 71 条
[41]   The 1-127 HA2 construct of influenza virus hemagglutinin induces cell-cell hemifusion [J].
Leikina, E ;
LeDuc, DL ;
Macosko, JC ;
Epand, R ;
Epand, R ;
Shin, YK ;
Chernomordik, LV .
BIOCHEMISTRY, 2001, 40 (28) :8378-8386
[42]  
Lloyd-Williams P., 1997, CHEM APPROACHES SYNT
[43]   The membrane topology of the fusion peptide region of influenza hemagglutinin determined by spin-labeling EPR [J].
Macosko, JC ;
Kim, CH ;
Shin, YK .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 267 (05) :1139-1148
[44]   ORIENTATION AND STRUCTURE OF THE NH2-TERMINAL HIV-1 GP41 PEPTIDE IN FUSED AND AGGREGATED LIPOSOMES [J].
MARTIN, I ;
DEFRISEQUERTAIN, F ;
DECROLY, E ;
VANDENBRANDEN, M ;
BRASSEUR, R ;
RUYSSCHAERT, JM .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1145 (01) :124-133
[45]   Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer [J].
Martin, I ;
Schaal, H ;
Scheid, A ;
Ruysschaert, JM .
JOURNAL OF VIROLOGY, 1996, 70 (01) :298-304
[46]   THE AMINO-TERMINAL PEPTIDE OF HIV-1 GLYCOPROTEIN-41 FUSES HUMAN ERYTHROCYTES [J].
MOBLEY, PW ;
LEE, HF ;
CURTAIN, CC ;
KIRKPATRICK, A ;
WARING, AJ ;
GORDON, LM .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1995, 1271 (2-3) :304-314
[47]   Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41 [J].
Muñoz-Barroso, I ;
Durell, S ;
Sakaguchi, K ;
Appella, E ;
Blumenthal, R .
JOURNAL OF CELL BIOLOGY, 1998, 140 (02) :315-323
[48]   INTERACTION OF THE HIV-1 FUSION PEPTIDE WITH PHOSPHOLIPID-VESICLES - DIFFERENT STRUCTURAL REQUIREMENTS FOR FUSION AND LEAKAGE [J].
NIEVA, JL ;
NIR, S ;
MUGA, A ;
GONI, FM ;
WILSCHUT, J .
BIOCHEMISTRY, 1994, 33 (11) :3201-3209
[49]   Destabilization and fusion of zwitterionic large unilamellar lipid vesicles induced by a β-type structure of the HIV-1 fusion peptide [J].
Nieva, JL ;
Nir, S ;
Wilschut, J .
JOURNAL OF LIPOSOME RESEARCH, 1998, 8 (02) :165-182
[50]  
PARKANZKY PD, UNPUB